Hansa Biopharma AB (publ) (STO:HNSA)
26.86
+0.66 (2.52%)
Jul 24, 2025, 5:29 PM CET
Hansa Biopharma AB Employees
Hansa Biopharma AB had 135 employees as of December 31, 2024. The number of employees decreased by 33 or -19.64% compared to the previous year.
Employees
135
Change (1Y)
-33
Growth (1Y)
-19.64%
Revenue / Employee
1.40M SEK
Profits / Employee
-4.26M SEK
Market Cap
2.28B
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Swedish Orphan Biovitrum AB | 1,806 |
Sectra AB | 1,296 |
Getinge AB | 11,791 |
Camurus AB | 256 |
Medicover AB | 47,256 |
Asker Healthcare Group AB | 4,030 |
AddLife AB | 2,181 |
Bonesupport Holding AB | 139 |
Hansa Biopharma AB News
- 7 days ago - Hansa Biopharma AB (publ) 2025 Q2 - Results - Earnings Call Presentation - Seeking Alpha
- 7 days ago - Hansa Biopharma AB (publ) (HNSBF) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Hansa Biopharma Reports Second Quarter and Interim January-June 2025 Financial Results - PRNewsWire
- 16 days ago - Hansa Biopharma appoints Dr Richard Philipson as Chief Medical Officer - PRNewsWire
- 24 days ago - Hansa Biopharma presents positive outcomes of five-year follow-up study of imlifidase in kidney transplantation at ESOT Congress 2025 in London - PRNewsWire
- 6 weeks ago - Hansa Biopharma to attend BIO International Convention - PRNewsWire
- 6 weeks ago - Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025 - PRNewsWire
- 2 months ago - Hansa Biopharma data at the 2025 PNS Annual Meeting demonstrates potential of imlifidase in the treatment of GBS - PRNewsWire